Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.96
+0.01000.13%
Post-market: 7.960.00000.00%19:13 EDT
Volume:22.27K
Turnover:177.76K
Market Cap:54.09M
PE:-0.70
High:8.15
Open:7.94
Low:7.80
Close:7.95
Loading ...

Atara Biotherapeutics Q1 Revenue USD 98.149 Million

THOMSON REUTERS
·
15 May

Atara Biotherapeutics Inc - Expects 65% Reduction in Operating Expenses in 2025

THOMSON REUTERS
·
15 May

Atara Biotherapeutics Q1 EPS USD 3.5

THOMSON REUTERS
·
15 May

Atara Biotherapeutics Prices $16 Million Share Offering to Fund Cancer and Autoimmune Therapies

Reuters
·
15 May

Atara Biotherapeutics Inc - Prices Offering of 834,237 Shares at $6.61 per Share

THOMSON REUTERS
·
15 May

Atara Biotherapeutics Announces Pricing of $16 Million Offering

THOMSON REUTERS
·
15 May

Atara Biotherapeutics Announces Major Workforce Reduction

TIPRANKS
·
13 May

BRIEF-Atara Biotherapeutics To Reduce Workforce By 30%

Reuters
·
13 May

Atara Biotherapeutics Inc - to Incur $1.4 Million in Severance Costs - SEC Filing

THOMSON REUTERS
·
13 May

Atara Biotherapeutics Announces Workforce Reduction Impacting 30% of Employees in Strategic Reorganization

Reuters
·
13 May

BRIEF-Atara Biotherapeutics Says FDA Lifts Clinical Hold Enabling Resumption Of Clinical Trials

Reuters
·
06 May

Atara Biotherapeutics Inc - FDA Has Granted a Type a Meeting to Discuss Path Forward for Bla

THOMSON REUTERS
·
06 May

Atara Biotherapeutics Inc - FDA Lifts Clinical Hold Enabling Resumption of Clinical Trials

THOMSON REUTERS
·
06 May

Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)

Business Wire
·
06 May

Atara Biotherapeutics Inc expected to post a loss of $1.98 a share - Earnings Preview

Reuters
·
05 May

BRIEF-Atara Biotherapeutics Inc - On March 31, Entered Amendment To Commercialization Agreement With Pierre Fabre - SEC Filing

Reuters
·
05 Apr

Atara Biotherapeutics Inc - Pierre Fabre to Assume Costs for FDA Remediation to Support Bla Resubmission for Tab-Cel - SEC Filing

THOMSON REUTERS
·
05 Apr

Atara Biotherapeutics Inc - Bio to Receive up to $550 Mln in Milestone Payments - SEC Filing

THOMSON REUTERS
·
05 Apr

Atara Biotherapeutics Inc - on March 31, Entered Amendment to Commercialization Agreement With Pierre Fabre - SEC Filing

THOMSON REUTERS
·
05 Apr

BRIEF-Atara Biotherapeutics Inc - Eric Hyllengren To Step Down As CFO And COO Of Atara Biotherapeutics - SEC Filing

Reuters
·
01 Apr